Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-26-092515
Filing Date
2026-08-07
Accepted
2026-08-07 11:23:22
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12141
2 EXHIBIT 99.1 tm2622175d1_ex99-1.htm EX-99.1 18486
  Complete submission text file 0001104659-26-092515.txt   32347
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Subject) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88073 | Film No.: 261252489
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address FRANKFURTER STR. 250 DARMSTADT 2M 64293
Business Address FRANKFURTER STR. 250 DARMSTADT 2M 64293 004961517245950
Merck KGaA (Filed by) CIK: 0001764133 (see all company filings)

EIN.: 980233737 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SCHEDULE 13G/A